CD40 and diabetic retinopathy: We investigated the CD40-TRAF6 axis in the onset of diabetic retinopathy in streptozotocin (STZ)-induced diabetic mice using a small molecule inhibitor (SMI-6877002), which can pass the blood-retina barrier [9, 10].